摘要
目的探讨溶栓治疗时间窗对急性心肌梗死后血管再通的影响。方法回顾性分析37例AMI患者的溶栓疗效,根据发病后溶栓时间分为早期治疗组(0~6h)和延迟治疗组(6~12h)。结果早期治疗(0~6h)组血管再通率(79.17%)与延迟治疗(>6~12h)组的61.54%相比较,差异有统计学意义(P<0.05);两组5周病死率、反复心绞痛和反复Ⅱ度以上房室传导阻滞(AVB)相比,差异有统计学意义(P<0.01)。结论AMI发病后6h内溶栓治疗,血管再通效果最好,住院病死率最低,但发病时间>6~12h的溶栓治疗仍可取得较好的效果。
Objective To investigate the clinical value of revascularization in the different time after acute myocardial infarction (AMI)treated with thrombolytic therapy. Methods The 37 patients were divided into 2 groups according to thrombolytic time after AMI. Results The difference in the reopen rate of blood vessel between earlier therapy(0 - 6 h) and delayed therapy( 〉 6 - 12 h) were significant (79. 17% ,61.54% ,P 〈 0.05 ) , the difference of mortality, repeating angina pectoris, Ⅱ degree atrioventrieular block during 5 weeks between these two groups were highly signifieant(P 〈0. 01 ). Conclusion Thrombolytic therapy in 6 hours after AMI has better effect but delayed therapy( 〉 6 - 12 h)still has moderate effect.
出处
《中国实用医药》
2008年第30期70-71,共2页
China Practical Medicine
关键词
急性心肌梗死
溶栓疗法
尿激酶
Acute myocardial infarction
Thrombolytie therapy
Urokimase